Panbela Therapeutics, Inc. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/bbdf2120-af43-40d4-8492-f683f45d9927/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2014 | $1.4M | 2014-01-01 – 2014-12-31 | evidence 0001477932-15-001973 |
| FY 2013 | $299.9k | 2013-01-01 – 2013-12-31 | evidence 0001477932-14-001315 |
| FY 2012 | $674.3k | 2012-01-01 – 2012-12-31 | evidence 0001477932-13-001328 |
| FY 2011 | $267.7k | 2011-01-01 – 2011-12-31 | evidence 0001477932-13-001328 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Panbela Therapeutics, Inc. — all facts · Net Income · Operating Income